A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Status:
Withdrawn
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and efficacy in topical
administration of differing dosing regimens of ISV-101 (Bromfenac in DuraSite® ophthalmic
solution) compared to Vehicle and DuraSite alone.